Phase II Randomized, Double-Blind, Placebo and Active Controlled, Multicenter, Parallel Group Proof of Concept Study of the Analgesic Effects of RN624 [tanezumab] in Adult Patients With Chronic Low Back Pain

Trial Profile

Phase II Randomized, Double-Blind, Placebo and Active Controlled, Multicenter, Parallel Group Proof of Concept Study of the Analgesic Effects of RN624 [tanezumab] in Adult Patients With Chronic Low Back Pain

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Oct 2011

At a glance

  • Drugs Tanezumab (Primary) ; Naproxen
  • Indications Back pain
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 16 Oct 2008 Actual number of patients (225) added as reported by CT.gov
    • 02 Oct 2008 Status changed from recruiting to completed as reported by CT.gov
    • 07 Jun 2008 The expected completion date for this trial is now 1 Sep 2008, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top